Mainstream

Y-mAbs Therapeutics GAAP EPS of -$0.07 beats by $0.19, revenue of $19.53M beats by $1.13M

Y-mAbs Therapeutics GAAP EPS of -$0.07 beats by $0.19, revenue of $19.53M beats by $1.13M

Post ContentymabRead More

You might also be interested in reading JPMorgan U.S. Research Enhanced Large Cap ETF declares quarterly distribution of $0.1521.

August 8, 2025
In Mainstream